ISSN: 2161-0681

Revista de patología clínica y experimental

Acceso abierto

Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Indexado en
  • Índice Copérnico
  • Google Académico
  • sherpa romeo
  • Abrir puerta J
  • Revista GenámicaBuscar
  • TOC de revistas
  • Directorio de publicaciones periódicas de Ulrich
  • Búsqueda de referencia
  • Universidad Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • publones
  • Fundación de Ginebra para la educación y la investigación médicas
  • Pub Europeo
  • ICMJE
Comparte esta página

Abstracto

Valproate Level Variation with Menstrual Cycle Phase in Bipolar Disorder

Feng Liu, Rui Zhu, Xiaopeng Deng, Chengguo Peng, Song Qin, Bo Liu

Objectives: The purpose of this study was to investigate the changes in serum valproate (VPA) levels and their relationship to progesterone levels during the menstrual cycles of fertile women.

Materials and methods: Female patients compliant with VPA (n=14) were included in this study. Serum VPA and progesterone levels were measured during two periods, in which progesterone levels may be the lowest (early follicular phase) and the highest (mid luteal phase).

Results: Serum VPA levels were significantly different between the two periods. Serum progesterone levels increased in 64.3% of the sample during menstruation, revealed a noticeable but not significant mean increased. There was no correlation between serum valproate and progesterone levels (r=0.209, p>0.05) in the menstrual phase.

Conclusion: This study shows that serum VPA levels varied greatly during the menstrual cycles. The results of this study also implying that VPA levels may be relationship to sex steroid levels in menstrual cycle. Particularly in cyclic premenstrual exacerbation of affective symptoms, this interaction should be considered in the evaluation of treatment may be beneficial.